Peter J Krause Selected Research

Peter J Krause Research Topics

Disease

25	Babesiosis (Piroplasmosis) 03/2024 - 05/2002
17	Infections 04/2023 - 09/2002
10	Lyme Disease (Disease, Lyme) 04/2023 - 05/2002
6	Parasitemia 01/2023 - 01/2003
3	Relapsing Fever 01/2018 - 03/2015
2	Tick-Borne Diseases (Tick-Borne Disease) 11/2021 - 11/2006
2	Rheumatoid Arthritis 10/2019 - 11/2007
2	Erythema 04/2014 - 09/2003
2	Malaria 02/2008 - 12/2007
2	Persistent Infection 02/2008 - 12/2006
2	Ehrlichiosis 09/2003 - 10/2002
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2023
1	Meningoencephalitis 07/2022
1	Leprosy (Hansen's Disease) 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2019
1	Neoplasms (Cancer) 07/2019
1	Chronic Urticaria 10/2015
1	Sepsis (Septicemia) 10/2015
1	Whooping Cough (Pertussis) 10/2015
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2013
1	Thalassemia 07/2012
1	Communicable Diseases (Infectious Diseases) 07/2011
1	Disease Progression 02/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2008
1	Autoimmune Diseases (Autoimmune Disease) 11/2007
1	Anemia 02/2007
1	Thrombocytopenia (Thrombopenia) 02/2007
1	Bites and Stings (Sting) 11/2006
1	Tick Bites 11/2006
1	Anaplasmosis 11/2006
1	Blister (Bulla) 09/2003
1	Hemolysis 01/2003

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 10/2002
6	AntigensIBA 01/2023 - 11/2007
6	Atovaquone (Mepron)FDA Link 01/2020 - 01/2003
5	Clindamycin (Cleocin)FDA LinkGeneric 01/2020 - 01/2003
5	Azithromycin (Zithromax)FDA LinkGeneric 01/2020 - 01/2003
5	Quinine (Quinson)FDA Link 01/2020 - 01/2003
3	EnzymesIBA 09/2017 - 11/2006
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 09/2008
2	Doxycycline (Periostat)FDA LinkGeneric 04/2023 - 10/2002
2	Anti-Infective Agents (Microbicides)IBA 02/2021 - 01/2020
2	AntibodiesIBA 01/2018 - 01/2016
2	ImmunosorbentsIBA 09/2017 - 11/2006
2	Peptides (Polypeptides)IBA 09/2017 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 11/2006
2	CytokinesIBA 12/2007 - 09/2003
1	Therapeutic UsesIBA 03/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2024
1	Erythromycin (Erycette)FDA LinkGeneric 04/2023
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2023
1	Penicillins (Penicillin)FDA Link 04/2023
1	Tetracycline (Achromycin)FDA LinkGeneric 04/2023
1	VaccinesIBA 01/2023
1	tafenoquineIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Clofazimine (Lamprene)FDA Link 01/2020
1	Etanercept (Enbrel)FDA Link 10/2019
1	Immunoglobulins (Immunoglobulin)IBA 07/2019
1	Drug CombinationsIBA 07/2019
1	Investigational DrugsIBA 07/2012
1	Rituximab (Mabthera)FDA Link 02/2008
1	OspA proteinIBA 11/2007
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Salivary Proteins and PeptidesIBA 11/2006
1	CalreticulinIBA 11/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2003
1	Interleukin-6 (Interleukin 6)IBA 09/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2002
1	Interferon-gamma (Interferon, gamma)IBA 09/2002

Therapy/Procedure

12	Therapeutics 03/2024 - 05/2002
9	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2013
3	Organ Transplantation 01/2022 - 01/2021
2	Length of Stay 11/2022 - 02/2021
2	Blood Component Removal (Apheresis) 10/2016 - 10/2015
1	Plasmapheresis 10/2015
1	Protective Clothing 01/2014
1	Donor Selection 07/2012
1	Drug Therapy (Chemotherapy) 02/2010